High-Grade Gliomas in Children-A Multi-Institutional Polish Study

Area of Science:

• Pediatric Oncology
• Neuro-oncology
• Clinical Research

Background:

• High-grade gliomas (HGG) are rare in children, leading to limited treatment data.
• Understanding long-term outcomes and survival factors is crucial for improving pediatric HGG care.

Purpose of the Study:

• To investigate long-term treatment results in pediatric HGG patients.
• To identify prognostic factors associated with improved survival in this population.

Main Methods:

• Retrospective analysis of 82 pediatric HGG patients with non-brainstem primary tumors.
• Utilized Cox proportional-hazard models and Kaplan-Meier methods for survival analysis.
• Evaluated impact of surgery, chemotherapy (including temozolomide), and radiotherapy on outcomes.

Main Results:

• Overall survival rates at 1, 2, 5, and 10 years were 78%, 48%, 30%, and 17%, respectively.
• Radical (R0) resection and temozolomide-based chemotherapy correlated with better overall survival.
• R0 resection and radical radiotherapy improved progression-free survival.

Conclusions:

• Pediatric HGG patients benefit from radical surgical resection.
• Temozolomide-based chemotherapy and radical radiotherapy are key components for improving survival.
• The optimal treatment involves R0 resection with immediate postoperative temozolomide chemotherapy and radical radiotherapy.